Galapagos Nv Stock Today
| GLPGF Stock | USD 26.26 1.60 6.49% |
Performance10 of 100
| Odds Of DistressLess than 9
|
Galapagos is trading at 26.26 as of the 26th of November 2024. This is a 6.49 percent up since the beginning of the trading day. The stock's lowest day price was 26.26. Galapagos has less than a 9 % chance of experiencing financial distress in the next few years and had a ok performance during the last 90 days. Equity ratings for Galapagos NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of December 2022 and ending today, the 26th of November 2024. Click here to learn more.
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium. Galapagos Genomics operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 65.84 M outstanding shares. More on Galapagos NV
Valuation
Check how we calculate scores
Galapagos Pink Sheet Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Galapagos NV [GLPGF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.85 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Galapagos's market, we take the total number of its shares issued and multiply it by Galapagos's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Galapagos NV classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 65.84 M outstanding shares.
Galapagos NV has accumulated about 4.43 B in cash with (503.83 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 67.38, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Galapagos Probability Of Bankruptcy
Ownership AllocationGalapagos NV has a total of 65.84 Million outstanding shares. Galapagos secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Galapagos Ownership Details
Galapagos NV Risk Profiles
| Mean Deviation | 0.2132 | |||
| Standard Deviation | 0.8185 | |||
| Variance | 0.6699 | |||
| Risk Adjusted Performance | 0.1035 |
Galapagos Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Galapagos without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Galapagos Corporate Management
| Andre Hoekema | Sr. VP of Corporate Devel. | Profile | |
| Elizabeth Goodwin | VP Corporate Communications & Investor Relations | Profile | |
| John Montana | Managing Argenta | Profile | |
| Michele MBA | Chief Board | Profile | |
| Walid AbiSaab | Member of the Executive Committee, Chief Medical Officer | Profile | |
| Marieke Vermeersch | Head Communication | Profile | |
| Chantal Tasset | Head Devel | Profile |
Other Information on Investing in Galapagos Pink Sheet
Galapagos financial ratios help investors to determine whether Galapagos Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Galapagos with respect to the benefits of owning Galapagos security.